Presently, most vaccines and drugs for COVID-19, including neutralizing antibodies (nAbs), target the spike protein of SARS-CoV-2 which anchors the coronavirus membrane and recognizes the receptor angiotensin-converting enzyme 2 (ACE2) [13,14,15,16,17]. Here, ACE2 is linked to COVID-19.